Single-cell analysis provides novel insights into elements of CAR T cell toxicities and response.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Journal of Hematology & Oncology Open Access 07 October 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Locke, F. L. et al. Lancet Oncol. 20, 31–42 (2019).
Schuster, S. J. et al. N. Engl. J. Med. 377, 2545–2554 (2017).
Neelapu, S. S. et al. N. Engl. J. Med. 377, 2531–2544 (2017).
Deng, Q. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1061-7 (2020).
Parker, K. R. et al. Cell 183, 126–142.e117 (2020).
Eshhar, Z. in Therapeutic Antibodies. Handbook of Experimental Pharmacology Vol. 181 (eds. Chernajovsky, Y. & Nissim A.) 329–342 (Springer, Berlin, Heidelberg, 2008).
Finney, O. C. et al. J. Clin. Invest. 129, 2123–2132 (2019).
Fraietta, J. A. et al. Nat. Med. 24, 563–571 (2018).
Das, R. K., Vernau, L., Grupp, S. A. & Barrett, D. M. Cancer Discov. 9, 492–499 (2019).
Sommermeyer, D. et al. Leukemia 30, 492–500 (2016).
Locke, F. L. et al. Blood Adv. 4, 4898–4911 (2020).
Norelli, M. et al. Nat. Med. 24, 739–748 (2018).
Gust, J. et al. Cancer Discov. 7, 1404–1419 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ramakrishna, S., Shah, N.N. Using single-cell analysis to predict CAR T cell outcomes. Nat Med 26, 1813–1814 (2020). https://doi.org/10.1038/s41591-020-01157-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-01157-w
This article is cited by
-
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Journal of Hematology & Oncology (2021)